DUTKO WORLDWIDE, LLC for BIOGENIDEC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Monitoring implementation and legislation affecting the health care IP and Medicare program, legislation to create a regulatory pathway for biosimiliars, Pathway for Biosimilars Act (H.R. 1548) and America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Physician Payments Sunshine Act of 2009 (S. 301).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CECIL SWAMIDOSS | — |
| KAREN TRAMONTANO | — |
| DARREN WILLCOX | — |
Health Issues HCR
Monitoring implementation and legislation affecting the Medicare program, legislation to create a regulatory pathway for biosimiliars, Pathway for Biosimilars Act (H.R. 1548) and America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Physician Payments Sunshine Act of 2009 (S. 301).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CECIL SWAMIDOSS | — |
| KAREN TRAMONTANO | — |
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Monitoring implementation and legislation affecting the Medicare program, legislation to create a regulatory pathway for biosimiliars, Pathway for Biosimilars Act (H.R. 1548) and America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Physician Payments Sunshine Act of 2009 (S. 301).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CECIL SWAMIDOSS | — |
| KAREN TRAMONTANO | — |
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.